Irisin: a potentially candidate marker for myocardial infarction

Area of Science:

• Cardiology
• Endocrinology
• Biochemistry

Background:

• Myocardial infarction (MI) disrupts the balance between oxygen supply and demand, leading to energy depletion.
• Irisin, a hormone produced by the heart, influences energy metabolism by increasing heat generation and reducing ATP production.
• Changes in irisin levels in circulation and cardiac tissue suggest a link between irisin and MI pathogenesis.

Purpose of the Study:

• To investigate the expression and concentration of irisin in response to isoproterenol (ISO)-induced myocardial infarction in rats.
• To determine the changes in irisin levels in cardiac tissue, skeletal muscle, kidney, and liver following MI.
• To assess the potential of serum irisin as a diagnostic marker for MI.

Main Methods:

• Rats were subjected to isoproterenol (ISO)-induced myocardial infarction and allocated into different time-point groups (1-24 hours).
• Immunohistochemistry was used to analyze irisin expression in cardiac, skeletal muscle, kidney, and liver tissues.
• Enzyme-linked immunosorbent assay (ELISA) was employed to measure serum irisin concentrations.

Main Results:

• Serum irisin levels significantly decreased from 1 to 24 hours post-MI, reaching a minimum at 2 hours.
• Irisin synthesis in cardiac muscle cells, kidney, liver, and skeletal muscle was reduced during the early phase (1-4 hours) after MI.
• While cardiac irisin synthesis remained suppressed, production in skeletal muscle, liver, and kidney showed signs of recovery after 6 hours.

Conclusions:

• The study provides novel insights into the role of irisin in the pathogenesis of myocardial infarction.
• The observed decrease in serum irisin concentration following MI suggests its potential utility as a diagnostic biomarker.
• Irisin expression and synthesis are dynamically altered in various tissues during MI, with differential recovery patterns observed.